Mithra receives approval in France to market hormone replacement therapy Tibelia

Women's health specialist Mithra has received a marketing authorisation (MA) for the commercialisation of Tibelia in France.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news